Experiment 324938

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEYIELD IS LESS THAN 50 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

PLATOMYCIN B

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismStreptosporangium violaceochromogenes (STREPTOSPORANGIACEAE)
CitationTAKASAWA,S: KAWAMOTO,I: TAKAHASHI,I: KOHAKURA,M: OKACHI,R: SATO,S: YAMAMOTO,M: SATO,T: NARA,T:. (1975). PLATOMYCINS A AND B. I. TAXONOMY OF THE PRODUCING STRAIN AND PRODUCTION, ISOLATION AND BIOLOGICAL PROPERTIES OF PLATOMYCINS.. 28()
Amount utilized
Compound isolated
Dose amount2.0 MG
Number15
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE